| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 383.535 | 401.498 | 385.216 | 371.855 | 357.515 | 161.286 | 224.894 | 252.502 | 265.546 | 242.314 |
| Total Income - EUR | 398.817 | 413.868 | 393.580 | 381.400 | 377.501 | 172.266 | 227.092 | 263.504 | 279.929 | 254.320 |
| Total Expenses - EUR | 272.337 | 275.764 | 296.222 | 268.401 | 268.096 | 196.862 | 179.326 | 201.418 | 220.770 | 190.722 |
| Gross Profit/Loss - EUR | 126.480 | 138.104 | 97.358 | 112.999 | 109.405 | -24.596 | 47.766 | 62.085 | 59.159 | 63.598 |
| Net Profit/Loss - EUR | 105.153 | 115.301 | 93.320 | 109.215 | 105.695 | -26.121 | 45.503 | 59.880 | 56.840 | 57.268 |
| Employees | 8 | 8 | 8 | 8 | 8 | 8 | 6 | 5 | 5 | 5 |
Check the financial reports for the company - Chemofin Prodcom S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.733 | 12.664 | 9.372 | 6.227 | 3.251 | 5.694 | 5.906 | 5.569 | 4.901 | 4.405 |
| Current Assets | 548.005 | 644.129 | 700.941 | 761.917 | 730.704 | 610.717 | 595.320 | 398.045 | 293.604 | 264.197 |
| Inventories | 128.471 | 128.859 | 150.400 | 128.365 | 126.861 | 78.422 | 94.454 | 106.558 | 103.014 | 90.205 |
| Receivables | 19.160 | 18.109 | 19.043 | 14.615 | 19.420 | 13.556 | 16.335 | 16.468 | 15.982 | 20.137 |
| Cash | 314.004 | 409.115 | 399.654 | 486.528 | 322.951 | 518.739 | 484.531 | 275.020 | 174.607 | 153.856 |
| Shareholders Funds | 459.266 | 465.802 | 485.568 | 585.871 | 108.298 | 80.124 | 123.850 | 182.289 | 238.576 | 57.483 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 92.035 | 191.718 | 225.480 | 182.932 | 626.230 | 537.291 | 478.137 | 222.045 | 61.026 | 211.824 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2042 - 2042" | |||||||||
| CAEN Financial Year |
2042
|
|||||||||
Comments - Chemofin Prodcom S.r.l.